Biomarin

BioMarin sues to stop generic version of its $90K-a-year drug
Bizjournals.com
Mon, 02/6/17 - 10:04 pm
Biomarin
generics
Kuvan
Dr Reddy's
Biotech Investing: 3 Bold Predictions for 2017
Motley Fool
Fri, 01/6/17 - 09:47 am
biotech
Incyte
Biogen
Biomarin
Gilead Sciences
Illumina
7 of the Most Shocking Biotech Pipeline Blowups of 2016
Motley Fool
Sun, 12/4/16 - 12:37 pm
biotech
Alnylam
revusiran
Clovis Oncology
rociletinib
Celldex Therapeutics
Rintega
Eli Lilly
solanezumab
Novavax
RSV-F
Arrowhead
ARC-520
ARC-521
ARC-AAT
Biomarin
drisapersen
BioMarin’s Disappointing 3Q16 Earnings
Market Realist
Mon, 10/31/16 - 06:34 pm
Biomarin
earnings
Sarepta Therapeutics' Greatest Threat: Anthem?
Motley Fool
Mon, 10/17/16 - 11:41 am
Sarepta Therapeutics
Duchenne Muscular Dystrophy
Exondys 5
Biomarin
Anthem
FDA’s controversial OK for eteplirsen spurs second thoughts for a rejected rival at BioMarin
Endpoints
Thu, 10/13/16 - 03:33 pm
FDA
eteplirsen
Duchenne Muscular Dystrophy
Biomarin
Sarepta Therapeutics
3 Biotechs Most Likely to Be Acquired
Motley Fool
Tue, 10/11/16 - 09:45 pm
biotech
M&A
Incyte
Biomarin
Biogen
After Sarepta win, BioMarin appeals DMD patent ruling
BioPharma Dive
Fri, 09/23/16 - 09:35 am
Sarepta Therapeutics
Biomarin
patents
Duchenne Muscular Dystrophy
eteplirsen
Kyndrisa
BioMarin hits snag with latest rare disease drug
BioPharma Dive
Wed, 09/7/16 - 08:34 pm
Biomarin
Brineura
FDA
CLN2 disease
3 Biotech Stocks Could Be the Next Big Takeover Targets
24/7 Wall St
Wed, 08/31/16 - 09:20 am
biotech
M&A
Biomarin
Incyte
Tesaro
4 Biotech Buyout Targets for Gilead, Sanofi After Medivation Miss
Barron's
Tue, 08/23/16 - 11:11 am
biotech
M&A
Gilead Sciences
Sanofi
Medivation
Incyte
Biomarin
Tesaro
Seattle Genetics
Sarepta: The Competition Is At The Gate
Seeking Alpha
Fri, 08/12/16 - 09:53 am
Sarepta Therapeutics
eteplirsen
Biomarin
Summit Therapeutics
PTC Therapeutics
Duchenne Muscular Dystrophy
Why BioMarin's Shares Tumbled 11% in June
Motley Fool
Sun, 07/10/16 - 12:09 pm
Biomarin
M&A
Duchenne Muscular Dystrophy
Sanofi
drisapersen
Kyndrisa
BioMarin Pharmaceutical shares rise after possible takeover from Roche
CNBC
Thu, 07/7/16 - 04:02 pm
Biomarin
M&A
Roche
3 Plausible Buyout Scenarios Within Biotech
Seeking Alpha
Tue, 07/5/16 - 10:20 am
biotech
Acadia
AstraZeneca
Allergan
Biogen
Teva Pharmaceutical
Biomarin
Incyte
Ironwood
Medivation
Pfizer
Relypsa
Synergy Pharmaceuticals
M&A
These 15 Biotech Companies Could Be Takeover Targets
Barron's
Wed, 06/29/16 - 12:56 pm
biotech
M&A
Alder Biopharmaceuticals
Biomarin
Coherus Biosciences
Intercept Pharma
Ultragenyx
Seattle Genetics
Adamas Pharmaceuticals
Alexion
Clovis Oncology
Corbus Pharmaceuticals
Incyte
Prothena
Puma Biotechnology
Tesaro
Versartis
BioMarin climbs on rumors it may be Sanofi's Medivation backup
Fierce Pharma
Fri, 06/17/16 - 09:38 pm
Biomarin
Sanofi
Medivation
M&A
Biotech: Is the Rally Real?
Barron's
Thu, 06/2/16 - 04:01 pm
biotech
Prothena
Biomarin
Vertex Pharmaceuticals
Incyte
Celgene
Why BioMarin’s Bad News is Great for Sarepta
Barron's
Wed, 06/1/16 - 09:43 pm
Biomarin
Sarepta Therapeutics
Duchenne Muscular Dystrophy
eteplirsen
drisapersen
BioMarin to Stop Developing its Duchenne Muscle Disease Drug
Bloomberg
Tue, 05/31/16 - 09:56 pm
Biomarin
Duchenne Muscular Dystrophy
Kyndrisa

Pages